Lupin, Zydus Ink Pact to Co-Market Semaglutide Injection in India
Mumbai, Mar 17 (TNT): Lupin Limited on Tuesday said it has entered into a licensing and supply agreement with Zydus Lifesciences Limited to co-market semaglutide injection in India for the treatment of diabetes and related metabolic disorders. Under the agreement, Lupin will have semi-exclusive rights to […….]
